New Onset Type 1 Diabetes Urine Metabolomics
OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) · 01.01.2024
DOI: 10.25584/2405140 ↗Kurz gefasst
Fachartikel in der Zeitschrift OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information), erschienen am 01.01.2024. Verfasst von Lisa Bramer und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Gas chromatography-mass spectrometry-based metabolomics to identify molecular signatures of Type 1 Diabetes (T1D) in urine. We utilize three cohorts in different stages post-diagnosis: (1) new onset, (2) within one year of diagnosis and (3) after 6 years of diagnosis. There were 91 metabolites identified in all three datasets with complete data represented in each cohort dataset. Cohort 1 (CNMC): 32 T1D cases; 32 healthy controls siblings Cohort 2 (BDCD): 27 T1D cases; 27 healthy controls siblings Cohort 3 (IUSOM): 12 T1D cases; 20 healthy controls Cases and controls matched on sex and age
Schlagwörter
Zitieren
APA
Bramer, L., Webb‐Robertson, B., & Flores, J. E. (2024). New Onset Type 1 Diabetes Urine Metabolomics. OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information). https://doi.org/10.25584/2405140
Vancouver
Bramer L, Webb‐Robertson B, Flores JE. New Onset Type 1 Diabetes Urine Metabolomics. OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information). 2024. doi:10.25584/2405140
BibTeX
@article{Bramer2024,
author = {Bramer, Lisa and Webb‐Robertson, Bobbie‐Jo and Flores, Javier E.},
title = {New Onset Type 1 Diabetes Urine Metabolomics},
journal = {OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information)},
year = {2024},
doi = {10.25584/2405140}
}
EUVIMED